---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-006927"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2023-03-07T23:59:59+00:00"
generated_at: "2026-06-18T09:42:01.225296+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biostage appoints Jerry He as Chairman and CEO; David Green remains on Board

## Summary
- Jerry He appointed Chairman and CEO effective March 1, 2023, replacing David Green.
- David Green to remain on Board and support transition.
- He previously served as EVP of Bright Scholar Education and CEO of Noah Education.
- Biostage is a clinical-stage biotech developing regenerative medicine for esophageal cancer.
- Company plans to begin FDA-approved clinical trial for esophageal cancer.

## SEC filing metadata
- accession: 0001493152-23-006927
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2023-03-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-006927
- JSON: https://secwatch.observer/filing/0001493152-23-006927.json
- Plain text: https://secwatch.observer/filing/0001493152-23-006927.txt

## Key facts
- Executive change
  David Green resigned as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..
  - Action: resigned
  - Role: Chairman and Chief Executive Officer
  source text: in replacement of David Green in such roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm
- Executive change
  Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..
  - Action: appointed
  - Role: Chairman and Chief Executive Officer
  source text: Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.